Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of PF-06427878 in Healthy Males
NCT02237742Phase 1Completed
- Sponsor
- Pfizer
- Start
- Nov 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of PF-06427878 in Nonalcoholic steatohepatitis (NASH), sponsored by Pfizer. Primary endpoints: Area Under the Plasma Curve From Time Zero to Last Quantifiable Concentration at Day 1, Area under the Plasma Concentration-Time Curve From Time Zero extrapolated to Infinite Time at Day 1 and 4 more. Started Nov 2014; status: completed.
02
Drugs
PF-06427878
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02237742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02237742.